Home » Topics » BioWorld Science, Dermatologic

BioWorld Science, Dermatologic
RSS

Celtrix's SomatoKine enters phase II feasibility study for the treatment of burns

July 2, 1997

Cellegy's antiwrinkling product enters clinical trials

July 1, 1997

Preclinical results with Anika's INCERT promising

July 1, 1997

Antipruritogenic effect of Kochia Fructus extract and active components

June 26, 1997

Agents for psoriasis and cancers from Roche

June 20, 1997

RXR-selective compounds disclosed by Allergan

June 20, 1997

General Hospital Corp. and Shiseido disclose psoriastatin polypeptides

June 18, 1997

Tazorac approved in the U.S.

June 18, 1997

La Jolla Cancer Res. Found. discloses integrin-binding peptides

June 17, 1997

NYU grants Medco option to license adenosine A2 agonists

June 16, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 30, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 30, 2026.
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...